Verley, a precision fermentation startup, has raised €32 million to expand its production of beta-lactoglobulin (BLG) whey protein, aiming to enter the US market by late 2023. The funding will help scale up production and secure regulatory approvals, positioning BLG as a complementary protein source to traditional whey protein isolate (WPI) amid rising demand and supply challenges.
Verley's recent €32 million funding round signals a strong investment opportunity in precision fermentation, particularly for producing alternative dairy proteins like beta-lactoglobulin (BLG). This is a timely move given the rising demand for protein and challenges with plant proteins and whey protein isolate supply. For professionals tracking the food innovation space, focusing on precision fermentation technologies could unlock new market segments by addressing taste, texture, and solubility challenges in high-protein formulations.